Similar articles

• Are oxygen radicals responsible for the acute cardiotoxicity of doxorubicin?

  Piccinini F, Monti E, Paracchini L, Perletti G. Piccinini F, et al. Adv Exp Med Biol. 1990;264:349-52. doi: 10.1007/978-1-4684-5730-8_54. Adv Exp Med Biol. 1990. PMID: 2244512 No abstract available.
• Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity.

  Mitra MS, Donthamsetty S, White B, Latendresse JR, Mehendale HM. Mitra MS, et al. Toxicol Appl Pharmacol. 2007 Nov 15;225(1):90-101. doi: 10.1016/j.taap.2007.07.018. Epub 2007 Aug 21. Toxicol Appl Pharmacol. 2007. PMID: 17904602
• β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB₂) receptors in rats.

  Meeran MFN, Al Taee H, Azimullah S, Tariq S, Adeghate E, Ojha S. Meeran MFN, et al. Chem Biol Interact. 2019 May 1;304:158-167. doi: 10.1016/j.cbi.2019.02.028. Epub 2019 Mar 2. Chem Biol Interact. 2019. PMID: 30836069
• Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.

  Damiani RM, Moura DJ, Viau CM, Caceres RA, Henriques JAP, Saffi J. Damiani RM, et al. Arch Toxicol. 2016 Sep;90(9):2063-2076. doi: 10.1007/s00204-016-1759-y. Epub 2016 Jun 25. Arch Toxicol. 2016. PMID: 27342245 Review.
• Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms.

  Minotti G, Recalcati S, Menna P, Salvatorelli E, Corna G, Cairo G. Minotti G, et al. Methods Enzymol. 2004;378:340-61. doi: 10.1016/S0076-6879(04)78025-8. Methods Enzymol. 2004. PMID: 15038979 Review. No abstract available.